TH124135A - - Google Patents
Info
- Publication number
- TH124135A TH124135A TH801005666A TH0801005666A TH124135A TH 124135 A TH124135 A TH 124135A TH 801005666 A TH801005666 A TH 801005666A TH 0801005666 A TH0801005666 A TH 0801005666A TH 124135 A TH124135 A TH 124135A
- Authority
- TH
- Thailand
- Prior art keywords
- estradiol
- lactose
- levonorgestrel
- pharmaceuticals
- beta
- Prior art date
Links
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims abstract 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract 4
- 239000008101 lactose Substances 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 3
- 239000000654 additive Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims 3
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 1
- 230000000996 additive Effects 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 235000011837 pasties Nutrition 0.000 claims 1
- 229960005309 Estradiol Drugs 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 2
- 229960001616 Chlormadinone Acetate Drugs 0.000 abstract 2
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 abstract 2
- WWYNJERNGUHSAO-XUDSTZEESA-N Previfem Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 2
- -1 estradiol valerate (estradiol valerate) Chemical compound 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 201000010538 lactose intolerance Diseases 0.000 abstract 2
- 229960004400 levonorgestrel Drugs 0.000 abstract 2
- 239000006187 pill Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 abstract 1
- 229940011871 Estrogens Drugs 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Etivex Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 229940030484 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM ESTROGENS Drugs 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229960003309 dienogest Drugs 0.000 abstract 1
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229940046080 endocrine therapy drugs Estrogens Drugs 0.000 abstract 1
- 229960004766 estradiol valerate Drugs 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000546 pharmaceutic aid Substances 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Publications (2)
Publication Number | Publication Date |
---|---|
TH124135B TH124135B (th) | 2013-05-31 |
TH124135A true TH124135A (pt) | 2013-05-31 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burkman et al. | The evolution of combined oral contraception: improving the risk-to-benefit ratio | |
Schindler | The “newer” progestogens and postmenopausal hormone therapy (HRT) | |
Sitruk-Ware | Progestogens in hormonal replacement therapy: new molecules, risks, and benefits | |
McCormack | Dienogest: a review of its use in the treatment of endometriosis | |
Boschitsch et al. | Hypertension in women: the role of progesterone and aldosterone | |
AR082998A1 (es) | Asociacion farmaceutica para tratar y/o prevenir mioma y/o endometriosis, uso de resveratrol y progestogeno, composicion farmaceutica para tratamiento y/o prevencion de mioma y/o endometriosis, medicamento para tratamiento y/o prevencion de mioma y/o endometriosis, kit y metodo para tratamiento y/o prevencion de mioma y/o endometriosis | |
Sweeney et al. | Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
CN1946383B (zh) | 基于天然雌激素的多段式避孕制剂 | |
PE20070327A1 (es) | Composicion que comprende una progestina y un estrogeno | |
PE20080273A1 (es) | Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico | |
JP2010508275A5 (pt) | ||
Chiara Del Savio et al. | Drospirenone 4 mg-only pill (DOP) in 24+ 4 regimen: a new option for oral contraception | |
NO20022292L (no) | Nye topiske östrogenprogestogenpreparater med systemisk effekt | |
JP2008515909A5 (pt) | ||
Mueck et al. | Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women | |
AR054245A1 (es) | Oblea que contiene hormonas esteroides | |
Cagnacci | Hormonal contraception: venous and arterial disease | |
JP2008534533A5 (pt) | ||
London et al. | Rationale for eliminating the hormone-free interval in modern oral contraceptives | |
Benagiano et al. | Seventy‐five microgram desogestrel minipill, a new perspective in estrogen‐free contraception | |
JP2010539153A5 (pt) | ||
Sabbadin et al. | Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI | |
TH124135A (pt) | ||
Liao et al. | Androgen Receptors: 17β–Hydroxy–5α–Androstan–3–one and the Translocation of a Cytoplasmic Protein to Cell Nuclei in Prostate |